From the Second Department of Internal Medicine, Faculty of Medicine,
Kyushu University, Fukuoka, Japan.
Correspondence to Takanari Kitazono, MD, Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Maidashi 31-1, Higashi-ku, Fukuoka 812, Japan. E-mail kitazono{at}intmed2.med.kyushu-u.ac.jp
Background and
PurposeSerotonin is one of the most potent
constrictors of cerebral blood vessels and is implicated in several
pathological conditions, including migraine and cerebral
ischemia. Recent evidence has suggested that tyrosine kinase is
involved in vasocontractile responses. The objective of this study was
to test the hypothesis that activation of tyrosine kinase contributes
to serotonin-induced constriction of the basilar artery
in vivo.
MethodsUsing a cranial window in anesthetized
Sprague-Dawley rats, we examined effects of inhibitors of
tyrosine kinase and tyrosine phosphatase on constrictor responses of
the basilar artery to serotonin in vivo.
ResultsSerotonin (10-8,
10-7, and 10-6 mol/L) produced
constriction of the basilar artery by 12±2%, 27±2%, and 37±3%,
respectively. Genistein (3x10-6
mol/L), an inhibitor of tyrosine
kinase, did not affect baseline diameter of the basilar artery but
attenuated serotonin-induced vasoconstriction
(P<.05 versus control responses). Daidzein, an inactive
analogue of genistein, did not affect serotonin-induced
constriction of the basilar artery. Tyrphostin 47 (10-5
mol/L), another inhibitor of tyrosine kinase,
also attenuated serotonin-induced vasoconstriction, and
tyrphostin 63, an inactive analogue of tyrphostin 47, did not affect
the vasoconstriction. Sodium orthovanadate (10-5
mol/L), an inhibitor of tyrosine phosphatase,
enhanced serotonin-induced vasoconstriction. Phorbol
12,13-dibutyrate, a direct activator of protein kinase C,
also caused constriction of the basilar artery, which was not affected
by genistein or sodium orthovanadate.
ConclusionsThese results suggest that
serotonin-induced constriction of the basilar artery is
mediated, at least in part, by activation of tyrosine kinase in vivo.
Department
of Internal Medicine,
Cardiovascular Division,
University of Iowa College of Medicine,
Iowa City, Iowa
© 1998 American Heart Association, Inc.
Original Contributions
Role of Tyrosine Kinase in Serotonin-Induced Constriction of the Basilar Artery In Vivo
Editorial Comment
This article has been cited by other articles:
![]() |
P. A. Engel New onset migraine associated with use of soy isoflavone supplements Neurology, October 22, 2002; 59(8): 1289 - 1290. [Full Text] [PDF] |
||||
![]() |
J. Kitayama, T. Kitazono, S. Ibayashi, M. Wakisaka, Y. Watanabe, M. Kamouchi, T. Nagao, M. Fujishima, and F. M. Faraci Role of Phosphatidylinositol 3-Kinase in Acetylcholine-Induced Dilatation of Rat Basilar Artery Editorial Comment Stroke, October 1, 2000; 31(10): 2487 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grumann-Júnior, M. A. Dias, R. V. Alves, J. E. Boteon, and J. B. Calixto Mechanisms Mediating Substance P-Induced Contraction in the Rat Iris In Vitro Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1861 - 1870. [Abstract] [Full Text] |
||||
![]() |
J. A. Madden and N. J. T. Christman Integrin signaling, free radicals, and tyrosine kinase mediate flow constriction in isolated cerebral arteries Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2264 - H2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Elliott, D. J. Lacey, W. M. Chilian, and A. K. Brzezinska Peroxynitrite is a contractile agonist of cerebral artery smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1585 - H1591. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |